Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1958 1
1964 1
1966 1
1967 1
1968 11
1969 4
1971 1
1972 1
1973 1
1974 1
1975 1
1976 2
1977 3
1978 3
1980 1
1981 5
1982 7
1983 3
1984 3
1985 5
1986 4
1987 2
1988 16
1989 8
1990 13
1991 5
1992 10
1993 13
1994 8
1995 7
1996 7
1997 6
1998 13
1999 6
2000 7
2001 11
2002 8
2003 9
2004 8
2005 17
2006 13
2007 13
2008 17
2009 16
2010 29
2011 22
2012 25
2013 26
2014 27
2015 21
2016 29
2017 24
2018 19
2019 41
2020 53
2021 52
2022 43
2023 6
Text availability
Article attribute
Article type
Publication date

Search Results

650 results
Results by year
Filters applied: . Clear all
Page 1
REFLECT-a phase 3 trial comparing efficacy and safety of lenvatinib to sorafenib for the treatment of unresectable hepatocellular carcinoma: an analysis of Japanese subset.
Yamashita T, Kudo M, Ikeda K, Izumi N, Tateishi R, Ikeda M, Aikata H, Kawaguchi Y, Wada Y, Numata K, Inaba Y, Kuromatsu R, Kobayashi M, Okusaka T, Tamai T, Kitamura C, Saito K, Haruna K, Okita K, Kumada H. Yamashita T, et al. Among authors: numata k. J Gastroenterol. 2020 Jan;55(1):113-122. doi: 10.1007/s00535-019-01642-1. Epub 2019 Nov 12. J Gastroenterol. 2020. PMID: 31720835 Free PMC article. Clinical Trial.
CheckMate 040 cohort 5: A phase I/II study of nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh B cirrhosis.
Kudo M, Matilla A, Santoro A, Melero I, Gracián AC, Acosta-Rivera M, Choo SP, El-Khoueiry AB, Kuromatsu R, El-Rayes B, Numata K, Itoh Y, Di Costanzo F, Crysler O, Reig M, Shen Y, Neely J, Tschaika M, Wisniewski T, Sangro B. Kudo M, et al. Among authors: numata k. J Hepatol. 2021 Sep;75(3):600-609. doi: 10.1016/j.jhep.2021.04.047. Epub 2021 May 26. J Hepatol. 2021. PMID: 34051329 Free article.
Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis.
Yau T, Hsu C, Kim TY, Choo SP, Kang YK, Hou MM, Numata K, Yeo W, Chopra A, Ikeda M, Kuromatsu R, Moriguchi M, Chao Y, Zhao H, Anderson J, Cruz CD, Kudo M. Yau T, et al. Among authors: numata k. J Hepatol. 2019 Sep;71(3):543-552. doi: 10.1016/j.jhep.2019.05.014. Epub 2019 Jun 7. J Hepatol. 2019. PMID: 31176752 Free article. Clinical Trial.
Complexity of Spider Dragline Silk.
Malay AD, Craig HC, Chen J, Oktaviani NA, Numata K. Malay AD, et al. Among authors: numata k. Biomacromolecules. 2022 May 9;23(5):1827-1840. doi: 10.1021/acs.biomac.1c01682. Epub 2022 Apr 4. Biomacromolecules. 2022. PMID: 35378031 Free PMC article. Review.
Raman image-activated cell sorting.
Nitta N, Iino T, Isozaki A, Yamagishi M, Kitahama Y, Sakuma S, Suzuki Y, Tezuka H, Oikawa M, Arai F, Asai T, Deng D, Fukuzawa H, Hase M, Hasunuma T, Hayakawa T, Hiraki K, Hiramatsu K, Hoshino Y, Inaba M, Inoue Y, Ito T, Kajikawa M, Karakawa H, Kasai Y, Kato Y, Kobayashi H, Lei C, Matsusaka S, Mikami H, Nakagawa A, Numata K, Ota T, Sekiya T, Shiba K, Shirasaki Y, Suzuki N, Tanaka S, Ueno S, Watarai H, Yamano T, Yazawa M, Yonamine Y, Di Carlo D, Hosokawa Y, Uemura S, Sugimura T, Ozeki Y, Goda K. Nitta N, et al. Among authors: numata k. Nat Commun. 2020 Jul 10;11(1):3452. doi: 10.1038/s41467-020-17285-3. Nat Commun. 2020. PMID: 32651381 Free PMC article.
650 results